Abstract:Breast cancer (BC) is the most prevalent cancer in women worldwide. A systematic approach to BC treatment, comprising adjuvant and neoadjuvant chemotherapy (NAC), as well as hormone therapy, forms the foundation of the disease’s therapeutic strategy. The extracellular matrix (ECM) is a dynamic network that exerts a robust biological effect on the tumor microenvironment (TME), and it is highly regulated by several immunological components, such as chemokines and cytokines. It has been established that the ECM promotes the development of an immunosuppressive TME. Therefore, while analyzing the ECM of BC, immune-related genes must be considered. In this study, we used bioinformatic approaches to identify the most valuable ECM-related immune genes. We used weighted gene co-expression network analysis to identify the immune-related genes that potentially regulate the ECM and then combined them with the original ECM-related gene set for further analysis. Least absolute shrinkage and selection operator (LASSO) regression and SurvivalRandomForest were used to narrow our ECM-related gene list and establish an ECM index (ECMI) to better delineate the ECM signature. We stratified BC patients into ECMI high and low groups and evaluated their clinical, biological, and genomic characteristics. We found that the ECMI is highly correlated with long-term BC survival. In terms of the biological process, this index is positively associated with the cell cycle, DNA damage repair, and homologous recombination but negatively with processes involved in angiogenesis and epithelial–mesenchymal transition. Furthermore, the tumor mutational burden, copy number variation, and DNA methylation levels were found to be related to the ECMI. In the Metabric cohort, we demonstrated that hormone therapy is more effective in patients with a low ECMI. Additionally, differentially expressed genes from the ECM-related gene list were extracted from patients with a pathologic complete response (pCR) to NAC and with residual disease (RD) to construct a neural network model for predicting the chance of achieving pCR individually. Finally, we performed qRT-PCR to validate our findings and demonstrate the important role of the gene OGN in predicting the pCR rate. In conclusion, delineation of the ECM signature with immune-related genes is anticipated to aid in the prediction of the prognosis of patients with BC and the benefits of hormone therapy and NAC in BC patients.

Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.

Recent progress on the effect of extracellular matrix on occurrence and progression of breast cancer

Cancer‐associated Fibroblasts in Breast Cancer: Challenges and Opportunities

The Role of Extracellular Matrix Proteins in Breast Cancer

Extracellular Matrix in Mammary Gland Development and Breast Cancer Progression

Extracellular matrix and its therapeutic potential for cancer treatment

Targeting extracellular matrix through phytochemicals: a promising approach of multi-step actions on the treatment and prevention of cancer

Targeting Extracellular Matrix Interaction in Gastrointestinal Cancer: Immune Modulation, Metabolic Reprogramming, and Therapeutic Strategies

Biomaterials to regulate tumor extracellular matrix in immunotherapy

The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

Combining Immune-Related Genes For Delineating the Extracellular Matrix and Predicting Hormone Therapy and Neoadjuvant Chemotherapy Benefits In Breast Cancer

The Extracellular Matrix and Vesicles Modulate the Breast Tumor Microenvironment

3D Extracellular Matrix Regulates the Activity of T Cells and Cancer Associated Fibroblasts in Breast Cancer

The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets

The Matrix Reloaded—The Role of the Extracellular Matrix in Cancer

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis

Extracellular Matrix Biomarkers in Colorectal Cancer

Extracellular Matrix and Cancer-associated Fibroblasts

The Extracellular Matrix and Hypoxia

Engineering extracellular matrix to improve drug delivery for cancer therapy